US 12,252,523 B2
Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species
Che il Moon, Daegu (KR); Seung Jun Yoo, Gyeongsan-si (KR); Chang-Hun Lee, Daegu (KR); So Yeon Kim, Daegu (KR); and Deok Ho Lee, Ansan-si (KR)
Assigned to SYLUS CO., LTD., Jeonju-si (KR)
Filed by SYLUS CO., LTD., Jeonju-si (KR)
Filed on Jul. 7, 2022, as Appl. No. 17/811,174.
Application 17/022,280 is a division of application No. 16/551,060, filed on Aug. 26, 2019, granted, now 10,808,018, issued on Oct. 20, 2020.
Application 17/811,174 is a continuation of application No. 17/022,280, filed on Sep. 16, 2020, abandoned.
Application 16/551,060 is a continuation of application No. PCT/KR2018/002396, filed on Feb. 27, 2018.
Claims priority of application No. 10-2017-0025370 (KR), filed on Feb. 27, 2017.
Prior Publication US 2022/0372094 A1, Nov. 24, 2022
Int. Cl. C07K 14/505 (2006.01); A61K 38/00 (2006.01); A61K 38/16 (2006.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); C07K 7/00 (2006.01); C07K 14/00 (2006.01); C07K 14/435 (2006.01); C07K 14/46 (2006.01); C07K 14/47 (2006.01); C07K 14/475 (2006.01); C12N 15/86 (2006.01); A61K 39/00 (2006.01); A61K 47/64 (2017.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 21/00 (2006.01); A61P 25/00 (2006.01); A61P 25/02 (2006.01); A61P 25/28 (2006.01); C07K 7/08 (2006.01); C07K 14/71 (2006.01); C12N 15/85 (2006.01); C12P 21/02 (2006.01); G01N 33/50 (2006.01); G01N 33/68 (2006.01)
CPC C07K 14/505 (2013.01) [A61K 38/1816 (2013.01); C07K 14/4702 (2013.01); C12N 15/86 (2013.01); A61K 38/00 (2013.01); A61K 38/1709 (2013.01); A61K 38/179 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/6031 (2013.01); A61K 47/64 (2017.08); A61K 2300/00 (2013.01); A61P 9/00 (2018.01); A61P 9/10 (2018.01); A61P 21/00 (2018.01); A61P 25/00 (2018.01); A61P 25/02 (2018.01); A61P 25/28 (2018.01); C07K 7/08 (2013.01); C07K 14/435 (2013.01); C07K 14/47 (2013.01); C07K 14/4705 (2013.01); C07K 14/71 (2013.01); C07K 2319/00 (2013.01); C07K 2319/70 (2013.01); C12N 15/85 (2013.01); C12P 21/02 (2013.01); G01N 33/5005 (2013.01); G01N 33/5044 (2013.01); G01N 33/5058 (2013.01); G01N 33/68 (2013.01); G01N 2800/52 (2013.01)] 7 Claims
 
1. A peptide comprising the amino acid sequence of SEQ ID NO: 18.